002044 美年健康
2025/09 - 九个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入6,925,390-3.01%10,701,99110,893,5358,615,6989,215,773
减:营业总成本6,747,900-2.75%9,931,1659,995,3758,861,4688,812,261
    其中:营业成本4,270,857-0.86%6,123,3396,232,3145,648,8215,579,561
               财务费用229,668-1.70%314,819299,024288,687349,970
               资产减值损失----(40,485)(88,787)(36,148)(21,850)
公允价值变动收益32,4972,166.97%4,41141,90319,0454,288
投资收益634-106.82%12,4497,578(3,620)69,924
    其中:对联营企业和合营企业的投资收益(17,930)-37.95%(16,627)(9,376)(46,126)5,132
营业利润163,91765.15%612,591883,705(407,657)389,926
利润总额138,32755.59%592,518848,055(450,720)364,753
减:所得税费用46,867460.33%183,528179,23250,862205,565
净利润91,46013.56%408,990668,823(501,582)159,188
减:非控股权益39,600-29.17%126,752163,20257,43997,609
股东净利润51,860110.53%282,238505,621(559,020)61,579

市场价值指针
每股收益 (元) *0.0100.00%0.0700.130-0.1400.020
每股派息 (元) *----0.0140.019----
每股净资产 (元) *2.0203.34%2.0211.9671.9052.054
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容